Botanists from the Smithsonian Tropical Research Institute (STRI) named the new species, Clusia nanophylla, because of the tiny size of the leaves, the smallest within the genus. This species has only ...

Shares of Recursion Pharmaceuticals (RXRX) spiked on Wednesday after the AI-driven drug developer significantly exceeded Street forecasts with its Q4 2025 financials, thanks primarily to a milestone ...

Add Yahoo as a preferred source to see more of our stories on Google. Dozens of trees at a much-loved city park have been damaged in the "worst example of vandalism" one council staff member has ever ...

A decision tree regression system incorporates a set of if-then rules to predict a single numeric value. Decision tree regression is rarely used by itself because it overfits the training data, and so ...

Bitterly cold arctic air has blanketed parts of the United States over the last week, with some areas getting snow and subzero temperatures. Along with the cold weather comes a natural event called ...

John Seiler was strolling across Virginia Tech’s campus with his students Thursday morning when something stopped them in their tracks: a sweet cherry tree with an unusual jagged scar running along ...

Severe cold temperatures hitting much of the country this week could branch out − literally. As people brace for the winter weather, some social media posts in recent days have warned of the chance ...

Recursive language models (RLMs) are an inference technique developed by researchers at MIT CSAIL that treat long prompts as an external environment to the model. Instead of forcing the entire prompt ...

Researchers at MIT's CSAIL published a design for Recursive Language Models (RLM), a technique for improving LLM performance on long-context tasks. RLMs use a programming environment to recursively ...

Dec 8 (Reuters) - Recursion Pharma (RXRX.O), opens new tab, which uses artificial intelligence to discover new drug candidates, said on Monday its experimental oral drug helped reduce abnormal growths ...

After twelve years at the helm of AI-drug developer Recursion, Chris Gibson will hand the CEO baton to Najat Khan, PhD, the company’s chief R&D officer and chief commercial officer, effective January ...